James J. Burns & Company LLC Sells 142 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

James J. Burns & Company LLC lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 0.9% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 16,365 shares of the company’s stock after selling 142 shares during the period. James J. Burns & Company LLC’s holdings in Henry Schein were worth $1,193,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. UniSuper Management Pty Ltd lifted its holdings in Henry Schein by 611.8% during the first quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock worth $1,034,000 after buying an additional 11,771 shares during the period. Envestnet Portfolio Solutions Inc. boosted its position in Henry Schein by 64.2% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after purchasing an additional 16,241 shares in the last quarter. Thompson Siegel & Walmsley LLC bought a new stake in Henry Schein during the second quarter valued at about $46,683,000. Nordea Investment Management AB grew its stake in Henry Schein by 8.9% in the first quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock valued at $744,000 after purchasing an additional 798 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock worth $1,165,425,000 after purchasing an additional 260,537 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $72.33 on Tuesday. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $62.05 and a twelve month high of $82.63. The company’s 50 day moving average is $70.66 and its 200 day moving average is $69.79. The company has a market cap of $9.16 billion, a PE ratio of 26.79, a price-to-earnings-growth ratio of 2.02 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter last year, the company posted $1.31 earnings per share. The firm’s revenue was up .0% compared to the same quarter last year. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Robert W. Baird cut their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. StockNews.com lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Friday, September 20th. Finally, JPMorgan Chase & Co. decreased their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $77.50.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.